Mark Sculpher is professor of health economics and director of the Centre for Health Economics, University of York. He is also co-director of the Policy Research Unit in Economic Evaluation of Health and Care Interventions, a programme of research for the UK Department of Health and Social Care funded by the National Institute for Health Research (NIHR).

Mark has worked in the field of economic evaluation and health technology assessment for over 30 years. He has researched in a range of clinical areas including heart disease, cancer, diagnostics, and public health. He has also contributed to research methods in the field, in particular relating to decision analytic modelling and techniques to handle uncertainty, heterogeneity and generalisability. He is also experienced in economic analysis in low- and middle-income settings. He has over 300 peer-reviewed publications and is a co-author of two major textbooks in the area: Methods for the Economic Evaluation of Health Care Programmes (OUP, 2015 with Drummond, Claxton, Torrance and Stoddart) and Decision Modelling for Health Economic Evaluation (OUP, 2006 with Briggs and Claxton).

Mark is an emeritus member of the UK NIHR College of Senior Investigators. He has been a member of the NICE Technology Appraisal Committee, the NICE Public Health Interventions Advisory Committee and NICE’s Diagnostics Advisory Committee. He has also been involved in advising NICE on methods over many years. Mark has also advised the UK House of Commons Health and Social Care Select Committee, as well as health systems internationally on health technology assessment methods including those in France, Ireland, Japan, Singapore, Germany, Portugal, Taiwan and New Zealand. He has been a member of the Commissioning Board for the UK NHS Health Technology Assessment Programme, the UK NIHR /Medical Research Council’s Methodology Research Panel and the UK Department of Health’s Policy Research Programme’s Commissioning Panel. He served as president of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (2011-12). Mark is a fellow of the UK Academy of Medical Sciences.